HealthcareAug 10, 2026

Beroni Group

Company Profile Analysis

Book Demo Subscribe Now

Year Founded & Workforce

2013-12-31

57 Employees

Industry

Healthcare

Services

Beroni Group Overview

Company Headquarters: Sydney, Australia

Founded: 2014

Workforce: ~57

Company Working: Beroni Group is a global biopharmaceutical company that is involved in the development of innovative drugs and therapies for the treatment of various diseases such as cancer and infectious disease. The company’s diverse product portfolio includes virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products, and a development pipeline targeting cancer and cell therapies. Beroni is majorly involved in developing and commercializing innovative immune cell therapies as well as new drugs to capture the unmet medical needs of cancer patients in China and worldwide. The company has operations in Australia, US, China, and Japan.

Strategy

Beroni Group focuses on forming alliances with various healthcare professionals around the globe to address peoples' requirements for advanced treatment. To enhance its product portfolio, the company also conducts research and development on medically supported and scientifically defined cell therapy and anticancer and infectious disease products. Moreover, the company is focused on developing the broadest range of antibody flagship brands and services, as well as on producing consumer and customer data insights. Additionally, it also focused on providing commercial excellence through its multichannel go-to-market methodology.

Company Snapshot

$1,186.9M

Revenue

Employees

2013-12-31

Founded

Sydney, Australia

Headquarters

Key Developments

Date	Approach	Development
August 2020	Collaboration	Beroni Group Limited announced a collaboration agreement with Genscript Biotech Corporation (US) for the development of a medical solution utilizing nanobody technology for COVID-19, particularly in leading pseudovirus neutralization test, humanization, and affinity maturation of nanobodies with the impartial of increasing the antibody affinity to target the antigen by five to ten-fold.

Product Offering

Beroni Group
- Nanobody

Financial Performance

A plan for every need

Forecast+

Get unlimited access to forecasts, charts, and company data across every research report on Wantstats.

USD200/mo

About the Author

Wantstats Research Team

Wantstats' research desk profiles Beroni Group as part of our ongoing coverage of the Healthcare sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Beroni Group

Company Headquarters: Sydney, Australia Founded: 2014 Workforce: ~57 Company Working: Beroni Group is a global biopharmaceutical company that is involved in the development of innovative drugs and therapies for the treatment of various diseases such as cancer and infectious disease. The company’s diverse product portfolio includes virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products, and a development pipeline targeting cancer and cell therapies. Beroni is majorly involved in developing and commercializing innovative immune cell therapies as well as new drugs to capture the unmet medical needs of cancer patients in China and worldwide. The company has operations in Australia, US, China, and Japan.

Starting from

$4,950